Upgrade to SI Premium - Free Trial

Iovance Biotherapeutics (IOVA)

5.17 -0.31 (5.66%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) July 17, 2026 5:15 PM - StreetInsider Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 30 July 2, 2026 5:02 PM - SEC Filing Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) June 19, 2026 5:15 PM - StreetInsider Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: WEISER MICHAEL June 18, 2026 5:17 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Dukes Iain D. June 18, 2026 5:17 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Countouriotis Athena June 18, 2026 5:16 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Maynard Ryan D June 18, 2026 5:16 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Puri Raj K. June 18, 2026 5:15 PM - SEC Filing Form S-8 IOVANCE BIOTHERAPEUTICS, June 18, 2026 5:05 PM - SEC Filing Form S-8 IOVANCE BIOTHERAPEUTICS, June 18, 2026 5:04 PM - SEC Filing Iovance Biotherapeutics (IOVA) files mixed shelf June 18, 2026 4:32 PM - StreetInsider Form S-3ASR IOVANCE BIOTHERAPEUTICS, June 18, 2026 4:32 PM - SEC Filing Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 04 June 10, 2026 5:01 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: Vogt Frederick G June 9, 2026 5:03 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: GRAF FINCKENSTEIN FRIEDRICH June 9, 2026 5:01 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: Puri Raj K. June 9, 2026 5:01 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: BILINSKY IGOR June 9, 2026 5:00 PM - SEC Filing Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - Globe NewsWire Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - StreetInsider Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: Vogt Frederick G June 3, 2026 5:02 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: Puri Raj K. June 3, 2026 5:01 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: GRAF FINCKENSTEIN FRIEDRICH June 3, 2026 5:01 PM - SEC Filing Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: BILINSKY IGOR June 3, 2026 5:00 PM - SEC Filing Iovance receives Australia approval for melanoma therapy Amtagvi June 3, 2026 4:09 PM - StreetInsider Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia June 3, 2026 4:05 PM - StreetInsider How Advanced Drug Delivery Could Improve Existing Cancer Treatments June 1, 2026 8:30 AM - StreetInsider Iovance receives FDA clearance for IL-12 tethered TIL therapy trial June 1, 2026 7:31 AM - StreetInsider Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001 June 1, 2026 7:30 AM - StreetInsider Iovanace Biotherapeutics (IOVA) Reiterated at Market Outperform by Citizens June 1, 2026 4:40 AM - StreetInsider Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) May 22, 2026 5:15 PM - StreetInsider Iovance Biotherapeutics to Present at Upcoming Conference May 21, 2026 8:05 AM - StreetInsider Form 4 IOVANCE BIOTHERAPEUTICS, For: May 11 Filed by: Kirby Daniel Gordon May 13, 2026 5:00 PM - SEC Filing Form SCHEDULE 13G IOVANCE BIOTHERAPEUTICS, Filed by: STATE STREET CORP May 12, 2026 11:17 AM - SEC Filing Intellia short interest rises most among biotech stocks in latest period - Baird May 12, 2026 9:58 AM - StreetInsider Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 07 May 7, 2026 9:18 AM - SEC Filing Form 10-Q IOVANCE BIOTHERAPEUTICS, For: Mar 31 May 7, 2026 9:17 AM - SEC Filing Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 5c ; Offers Guidance May 7, 2026 7:17 AM - StreetInsider Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates May 7, 2026 7:05 AM - Globe NewsWire Form ARS IOVANCE BIOTHERAPEUTICS, For: Dec 31 May 1, 2026 5:01 PM - SEC Filing Form DEFA14A IOVANCE BIOTHERAPEUTICS, April 28, 2026 5:05 PM - SEC Filing Form DEF 14A IOVANCE BIOTHERAPEUTICS, For: Jun 10 April 28, 2026 5:01 PM - SEC Filing Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026 April 27, 2026 8:01 AM - Globe NewsWire Full Article List